Can Avidity Biosciences Inc (RNA) Stock rise from its doldrums?
BofA Securities raised the price target for the Avidity Biosciences Inc (NASDAQ:RNA) stock to “a Buy”. The rating was released on May 03, 2024, according to finviz. The research report from Evercore ISI has upgraded the stock from In-line to Outperform, with a price target set at $20. The stock was downgraded by Evercore ISI, […]
Does Avidity Biosciences Inc (RNA) Stock have a positive outlook following recent trade?
BofA Securities raised the price target for the Avidity Biosciences Inc (NASDAQ:RNA) stock to “a Buy”. The rating was released on May 03, 2024, according to finviz. The research report from Evercore ISI has upgraded the stock from In-line to Outperform, with a price target set at $20. The stock was downgraded by Evercore ISI, […]
There is no better tap than Avidity Biosciences Inc (RNA) Stock
BofA Securities raised the price target for the Avidity Biosciences Inc (NASDAQ:RNA) stock to “a Buy”. The rating was released on May 03, 2024, according to finviz. The research report from Evercore ISI has upgraded the stock from In-line to Outperform, with a price target set at $20. The stock was downgraded by Evercore ISI, […]
A positive surprise is on the way: Avidity Biosciences Inc (RNA) Stock
BofA Securities raised the price target for the Avidity Biosciences Inc (NASDAQ:RNA) stock to “a Buy”. The rating was released on May 03, 2024, according to finviz. The research report from Evercore ISI has upgraded the stock from In-line to Outperform, with a price target set at $20. The stock was downgraded by Evercore ISI, […]
Avidity Biosciences Inc (RNA) Stock is poised for a successful quarter
BofA Securities raised the price target for the Avidity Biosciences Inc (NASDAQ:RNA) stock to “a Buy”. The rating was released on May 03, 2024, according to finviz. The research report from Evercore ISI has upgraded the stock from In-line to Outperform, with a price target set at $20. The stock was downgraded by Evercore ISI, […]
